[Cerebral radionecrosis after irradiation of a cancer of the cavum].
Meppiel
E
E
Service de neurologie, Centre Hospitalier de Meaux, Meaux.
Koumakis
E
E
Cret
C
C
Stefanizzi
S
S
Béroud
R
R
Améri
A
A
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D020208:Brain Injury, Chronic / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology; D001933:Brain Stem / Q000293:injuries / Q000473:pathology / Q000528:radiation effects*; D002277:Carcinoma / Q000188:drug therapy / Q000532:radiotherapy*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D016371:Cranial Irradiation / Q000009:adverse effects*; D003937:Diagnosis, Differential; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D020233:Gait Disorders, Neurologic / Q000209:etiology*; D006801:Humans; D006987:Hypesthesia / Q000209:etiology*; D008279:Magnetic Resonance Imaging; D009303:Nasopharyngeal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D010291:Paresis / Q000209:etiology*; D011832:Radiation Injuries / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology; D013702:Temporal Lobe / Q000293:injuries / Q000473:pathology / Q000528:radiation effects*
D001761:Bleomycin; D015251:Epirubicin; D002945:Cisplatin